David Tougeron: Does Prior Sporadic dMMR Primary CRC Increase the Rate of Secondary CRC
David Tougeron, Professor at Poitiers University Hospital, shared a post on LinkedIn:
“Happy to share the last paper of our digestive Oncology team of Poitiers showing a significant rate of secondary cancers in patients with a prior sporadic dMMR/MSI primary CRC but these cancers are pMMR/MSS (no new dMMR/MSI sporadic tumors due to MLH1 promotor hypermethylation).”
Title: Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer
Authors: Paul Franques, Pierre Moreau, Camille Evrard, Arnaud Chong-Si-Tsaon, Éric Frouin, Marie-Luce Auriault, Valérie Moulin, Audelaure Junca, Julie Godet, Lucie Lebeau, Roxane Aguillon, Gaëlle Tachon, Lucie Karayan-Tapon, David Tougeron
Read The Full Article at Sage Journals.
More posts featuring David Tougeron on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023